Mazdutide's Patent Journey: A Dual Agonist for Obesity and Diabetes
Patent landscape and therapeutic evolution of mazdutide: a dual GLP-1/Glucagon receptor agonist for obesity and type 2 diabetes.
Abstract
Patent landscape and therapeutic evolution of mazdutide: a dual GLP-1/Glucagon receptor agonist for obesity and type 2 diabetes.
Authors: Abdul Fasi M
Journal: Expert opinion on therapeutic patents (2026)
DOI: 10.1080/13543776.2026.2645812